The risk of invasive pneumococcal disease differs between risk groups in norway following widespread use of the 13-valent pneumococcal vaccine in children

HIGHLIGHTS

  • who: Brita Askeland Winje and colleagues from the Division of Infection Control and Environmental Health, Norwegian Institute of Public Health, POBox , have published the article: The Risk of Invasive Pneumococcal Disease Differs between Risk Groups in Norway Following Widespread Use of the 13-Valent Pneumococcal Vaccine in Children, in the Journal: Microorganisms 2021, 9, 1774. of 18/08/2021
  • what: The studies showed that the indirect effects of childhood vaccination had led in five years to an overall, nonsignificant decrease of 14% (95% CI -4%, 30%) in IPD in the elderly . The authors extended the . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?